Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Pulmonary Arterial Hypertension
Week in Review: At-home flu testing, asymptomatic monkeypox, telediagnostic accuracy, and more
Dear LabPulse.com member,
September 7, 2022
Elevated cfDNA levels linked to severity of PAH
The new blood test measures DNA fragments shed by damaged cells; according to the NIH, the test could also be used to predict survivability.
August 31, 2022
Clinical trial planned for COVID-19 rapid breath test
The investigational BreathTest-1000 mass spectrometer is being positioned as a noninvasive, self-administered test of breath samples for various COVID-19 strains. The developers envisage that relative to the gold standard for COVID-19 detection, polymerase chain reaction (PCR) tests, their product would be a lower-cost, more convenient option suitable for wide distribution.
October 20, 2020
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Page 1 of 1